Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
  1. 4 Open-market sale Executive Chairman sold 34,740 shares at an average $8.04 ($279,307)
  2. 4 Open-market sale Executive Chairman sold 2,305 shares at $7.57 ($17,445)
  3. 4 Open-market sale Executive Chairman sold 39,695 shares at an average $7.71 ($306,192)
  4. 4 Open-market sale Executive Chairman sold 12,212 shares at $7.09 ($86,616)
  5. 4 Open-market sale Executive Chairman sold 29,788 shares at an average $7.33 ($218,412)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Director acquired 240,000 shares (grant or award)
  15. 4 Grant or award Director acquired 320,000 shares (grant or award)
  16. 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
  18. 4 Grant or award Director acquired 1,260,000 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 14 · 263 filings